000			01967 a2200529 4500
005			20250515094321.0
264		0	_c20071221
008			200712s 0 0 eng d
022			_a0963-1801
024	7		_a10.1017/s0963180107070478 _2doi
040			_aNLM _beng _cNLM
100	1		_aKassirer, Jerome P
245	0	0	_aCommercialism and medicine: an overview. _h[electronic resource]
260			_bCambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees _c2007
300			_a377-86; discussion 439-42 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAttitude of Health Personnel
650	0	4	_aClinical Trials as Topic _xethics
650	0	4	_aCommerce _xethics
650	0	4	_aCommunication
650	0	4	_aConflict of Interest
650	0	4	_aCyclooxygenase 2 Inhibitors
650	0	4	_aDelivery of Health Care _xeconomics
650	0	4	_aDrug Approval
650	0	4	_aDrug Industry _xeconomics
650	0	4	_aEconomics, Medical _xethics
650	0	4	_aEducation, Medical _xstandards
650	0	4	_aEntrepreneurship _xethics
650	0	4	_aEthics, Medical
650	0	4	_aHealth Care Sector _xethics
650	0	4	_aHealth Occupations _xeconomics
650	0	4	_aHumans
650	0	4	_aInsurance, Health
650	0	4	_aMoral Obligations
650	0	4	_aPhysician-Patient Relations _xethics
650	0	4	_aPhysicians _xeconomics
650	0	4	_aPractice Guidelines as Topic
650	0	4	_aPublication Bias
650	0	4	_aSocial Values
650	0	4	_aSocieties, Medical
650	0	4	_aTrust
650	0	4	_aTruth Disclosure
650	0	4	_aUnited States
650	0	4	_aUnited States Food and Drug Administration
773	0		_tCambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees _gvol. 16 _gno. 4 _gp. 377-86; discussion 439-42
856	4	0	_uhttps://doi.org/10.1017/s0963180107070478 _zAvailable from publisher's website
999			_c17535353 _d17535353